Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

16 Feb 2021 | 04:00 pm |

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

The transaction transfers ownership of the brand portfolio, comprised of Flux®, Decubal®, Lactocare®, Apobase®, Dailycare® and Fludent® from Teva to Karo. The transactionis is expected to close on April 1.

The Pinsent Masons team was jointly led by partners Allistair Booth and Thilo Schneider and included senior associate Ciaran Wilkinson.

Commenting on the transaction Thilo Schneider said:

"I am so pleased that we have been able to support Teva and to have brought this transaction to a successful conclusion. The sale is significant for both parties and we are proud to have achieved a successful outcome for Teva. We worked closely with them to understand what they wanted to achieve and helped to determine the best options available to them." 

Latest press releases

Show me all press releases

Pinsent Masons advises Malaysia-based Tenaga Nasional Berhad (TNB) on first international offshore wind investment

Multinational law firm Pinsent Masons has advised Malaysian utility, TNB and Vantage RE, its UK/European arm, on its acquisition of a 49% stake in the offshore wind farm company Blyth Offshore Demonstrator Limited (BODL) from EDF Renewables.

Pinsent Masons advises UK Government on first purchase of Covid-19 antivirals

Multinational law firm Pinsent Masons has advised the UK government on its contracts for the purchase of significant volumes of two novel, Covid-19 specific, antivirals.

Pinsent Masons advises on purchase of Northern Ireland’s first major energy storage project

Multinational law firm Pinsent Masons has advised SUSI Partners on its purchase of a 50MW battery storage project from German renewables developer ABO Wind in Kells, Northern Ireland.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises UK Government on first purchase of Covid-19 antivirals

Multinational law firm Pinsent Masons has advised the UK government on its contracts for the purchase of significant volumes of two novel, Covid-19 specific, antivirals.

Pinsent Masons appoints leading Life Sciences IP partner in London

Multinational law firm Pinsent Masons has recruited Life Sciences partner Gina Bicknell, adding additional skills and strength to its Technology, Science and Industry (TSI) sector capabilities.

Pinsent Masons Advises NEXA Enterprise Asset Management on Acquisition By Transcat Inc

Multinational law firm Pinsent Masons has advised NEXA on its acquisition by Transcat Inc.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts